Loading clinical trials...
Loading clinical trials...
COMPLEMENT study (ChrOnic subdural hematoMa Patients suppLemented with Embolization of Middle mENingeal artery Trial) is a prospective, open label, blinded endpoint (PROBE), Japanese, two-arm, randomi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Kazutaka Uchida
NCT06163547 · Chronic Subdural Hematomas, Cerebral Compression Due to Injury
NCT06179017 · Mild Stroke, Acute Ischemic Stroke, and more
NCT05374681 · Chronic Subdural Hematoma
NCT07324551 · Chronic Subdural Hematoma, Hemorrhage Brain
NCT04861506 · Thromboembolic Disease, Lower Extremity Problem, and more
Hyogo Medical University
Nishinomiya, Hyōgo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions